Wiley Blackwell

SHERPA: Unknown

People

  1. Seshan
    Seshan
  2. Begg
    Begg
  3. Dogan
    Dogan
  4. Kumar
    Kumar
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Palomba
    Palomba
  8. Zelenetz
    Zelenetz
  9. Hamlin
    Hamlin
  10. Horwitz
    Horwitz

Groups

  1. Biostatistics Service (28)
  2. Center for Pancreatic Cancer Research (28)
  3. Epidemiology and Biostatistics (28)
  4. Department of Medicine (15)
  5. Survivorship Research (12)
  6. Population Sciences Research Program (11)
  7. Center for Hematologic Malignancies (8)
  8. Sloan Kettering Institute Faculty (8)
  9. Solid Tumor Oncology Division (8)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
Search Within
  1. "Venkatraman Seshan"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (7)
Groups
  1. Biostatistics Service (28)
  2. Center for Pancreatic Cancer Research (28)
  3. Epidemiology and Biostatistics (28)
  4. Department of Medicine (15)
  5. Survivorship Research (12)
  6. Population Sciences Research Program (11)

More Groups

People
  1. Venkatraman Seshan (28)
  2. Colin Begg (7)
  3. Anas Younes (6)
  4. Ahmet Dogan (5)
  5. Alison Moskowitz (5)
  6. Andrew Zelenetz (5)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2019 (4)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Biometrics (8)
  2. Cancer (8)
  3. Hematological Oncology (7)
  4. Cancer Medicine (1)
  5. International Statistical Review (1)
  6. Journal of the Royal Statistical Society Series B - Statistical Methodology (1)

More Publications

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
    Journal Article

    Luo, L.; Shen, R.; Arora, A.; Orlow, I.; Busam, K. J.; Lezcano, C.; Lee, T. K.; Hernando, E.; Gorlov, I.; Amos, C.; more...
    Pigment Cell & Melanoma Research (2022)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Testing tumors from different anatomic sites for clonal relatedness using somatic mutation data
    Journal Article

    Ostrovnaya, I.; Mauguen, A.; Seshan, V. E.; Begg, C. B.
    Biometrics (2021)

    Fulltext@MSK | Save
  • Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)
    Meeting Abstract

    Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical significance and outcomes in patients with diffuse large B‐cell lymphoma (DLBCL) harboring extra copies [EC] and/or translocations [TL] of MYC, BCL2, and BCL6
    Meeting Abstract

    Sermer, D.; Bobillo, S.; Seshan, V.; Dogan, A.; Younes, A.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Impact of pet imaging and histologic transformation on the prognosis of early disease progression in follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Hamlin, P.; Horwitz, S. M.; Kumar, A.; Matasar, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Estimating the probability of clonal relatedness of pairs of tumors in cancer patients
    Journal Article

    Mauguen, A.; Seshan, V. E.; Ostrovnaya, I.; Begg, C. B.
    Biometrics (2018)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Ni, A.; Soumerai, J.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save